Evidence map›Paper›PMID 26203778›Full record

ArticleNano letters2015

Activatable and Cell-Penetrable Multiplex FRET Nanosensor for Profiling MT1-MMP Activity in Single Cancer Cells.

Eddie Y Chung, Christopher J Ochs, Yi Wang, Lei Lei, Qin Qin, Andrew M Smith, Alex Y Strongin, Roger Kamm, Ying-Xin Qi, Shaoying Lu and 1 more

Abstract read
In one paragraph

Article in Nano letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Different Approaches to Develop Nanosensors for Diagnosis of Diseases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
  4. Review
  5. Article
  6. Review
  7. Frontiers in physics · 2019
    Article
  8. A DNA aptamer recognizing MMP14 forOncology letters · 2019
    Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Eddie Y Chung
Christopher J Ochs‡Singapore-MIT Alliance for Research and Technology, BioSystems and Micromechanics, Singapore 138602.
Yi Wang§Department of Bioengineering, University of Illinois at Urbana-Champaign, Champaign, Illinois 61801, United States.
Lei Lei§Department of Bioengineering, University of Illinois at Urbana-Champaign, Champaign, Illinois 61801, United States.
Qin Qin
Andrew M Smith§Department of Bioengineering, University of Illinois at Urbana-Champaign, Champaign, Illinois 61801, United States.
Alex Y Strongin∥Sanford Burnham Medical Research Institute, La Jolla, California 92037, United States.
Roger Kamm‡Singapore-MIT Alliance for Research and Technology, BioSystems and Micromechanics, Singapore 138602.
Ying-Xin Qi⊥Institute of Mechanobiology and Medical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
Shaoying Lu§Department of Bioengineering, University of Illinois at Urbana-Champaign, Champaign, Illinois 61801, United States.
Yingxiao Wang§Department of Bioengineering, University of Illinois at Urbana-Champaign, Champaign, Illinois 61801, United States.
La Jolla Bioengineering Institute · USSingapore-MIT Alliance for Research and Technology · SGUniversity of California, San Diego · USUniversity of Illinois Urbana-Champaign · USSanford Burnham Prebys Medical Discovery Institute · USShanghai Jiao Tong University · CN

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
Role of Spatiotemporal Epigenetic Dynamics in Regulating Endothelial Gene Expressions under FlowsR01HL121365 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHIEN, SHU, WANG, YINGXIAO · 2014 to 2025
$7.5M
FRET Imaging of Molecular Hierarchy at Subcellular Levels in MechanotransductionR01HL098472 · NHLBI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI WANG, YINGXIAO · 2010 to 2014
$1.9M
Microfluidic 3D Assays for Metastatic CancerR33CA174550 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI KAMM, ROGER D · 2013 to 2015
$1.1M
Next-Generation Quantum Dots for Molecular and Cellular Imaging of CancerR00CA153914 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI SMITH, ANDREW MICHAEL · 2012 to 2014
$709k
The Integration of FLIM and FRET for the Visualization of Flow-induced MolecularK02HL109142 · NHLBI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI WANG, YINGXIAO · 2011 to 2015
$549k
NCI NIH HHS 1R33CA174550NCI NIH HHS P30 CA030199NCI NIH HHS R00 CA153914NCI NIH HHS R00CA153914NCI NIH HHS R33 CA174550NHLBI NIH HHS HL098472NHLBI NIH HHS HL109142NHLBI NIH HHS HL121365NHLBI NIH HHS K02 HL109142NHLBI NIH HHS R01 HL098472NHLBI NIH HHS R01 HL121365
6 · The paper itself

Abstract

We developed a quantum-dot-based fluorescence resonance energy transfer (QD-FRET) nanosensor to visualize the activity of matrix metalloproteinase (MT1-MMP) at cell membrane. A bended peptide with multiple motifs was engineered to position the FRET pair at a close proximity to allow energy transfer, which can be cleaved by active MT1-MMP to result in FRET changes and the exposure of cell penetrating sequence. Via FRET and penetrated QD signals, the nanosensor can profile cancer cells.

Indexed as

Amino Acid SequenceBiosensing TechniquesCell Line, TumorFemaleFluorescence Resonance Energy TransferFluorescent DyesHeLa CellsHumansMatrix Metalloproteinase 14Models, MolecularMolecular Sequence DataNeoplasmsPeptidesQuantum DotsSingle-Cell AnalysisFluorescent DyesMatrix Metalloproteinase 14Peptidesactivatable cell-penetrating peptidecancerFRET nanosensorMT1-MMPmultiplex signalssingle cell

Identifiers

PMID26203778
PMCPMC4675668
OpenAlexW1206658652

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.